...
首页> 外文期刊>The Journal of Steroid Biochemistry and Molecular Biology >Medium doses of daily vitamin D decrease falls and higher doses of daily vitamin D3 increase falls: A randomized clinical trial
【24h】

Medium doses of daily vitamin D decrease falls and higher doses of daily vitamin D3 increase falls: A randomized clinical trial

机译:日剂量的每日维生素D减少落下,每日维生素D3增加较高的含量:随机临床试验

获取原文
获取原文并翻译 | 示例

摘要

Falls are a serious health problem in the aging population. Because low levels of vitamin D have been associated with increased fall rates, many trials have been performed with vitamin D; two meta-analyses showed either a small effect or no effect of vitamin D on falls. We conducted a study of the effect of vitamin D on serum 25 hydroxyvitamin D (25OHD) and data on falls was collected as a secondary outcome. In a 12-month double blind randomized placebo trial, elderly women, mean age 66 years, were randomized to one of seven daily oral doses of vitamin D or placebo. The main inclusion criterion for study was a baseline serum 25OI-ID < 20 ng/ml (50 nmol/L). A history of falls was collected at baseline and fall events were collected every 3 months. Results showed that the effect of vitamin D on falls followed a U-shaped curve whether analyzed by dose or serum 25OHD levels. There was no decrease in falls on low vitamin D doses 400, 800 IU, a significant decrease on medium doses 1600, 2400,3200 IU (p = 0.020) and no decrease on high doses 4000, 4800 IU compared to placebo (p = 0.55). When compared to 12-month serum 25OHD quintiles, the faller rate was 60% in the lowest quintile < 25 ng/ml (< 50 nmol/L), 21% in the low middle quintile 32-38 ng/ml (80-95 nmo/L), 72% in the high middle quintile 38-46 ng/ml (95-115 nmo/L) and 45% in the highest quintile 46-66 ng/ml (115-165 nmol/L). In the subgroup with a fall history, fall rates were 68% on low dose, 27% on medium doses and 100% on higher doses. Fall rates on high doses were increased compared to medium doses (Odds Ratio 5.6.95% CI; 2.1-14.8). In summary, the maximum decrease in falls corresponds to a 12- month serum 25OHD of 32-38 ng/ml (80-95 nmol/L) and faller rates increase as serum 25OHD exceed 40-45 ng/ml (100-112.5 nmol/L). The Tolerable upper limit (TUL) recently increased in 2010 from 2000 to 4000 IU/day may need to be reduced in elderly women especially in those with a fall history.
机译:跌倒是老龄化人口的严重健康问题。由于低水平的维生素D与下降率增加相关,因此许多试验已经使用维生素D进行;两种荟萃分析显示出少量效果或维生素D对瀑布的影响。我们进行了对维生素D对血清血清的影响的研究,将秋季的数据作为次要结果收集。在一个12个月的双盲随机安慰剂试验中,年长妇女,平均年龄为66岁,被随机分为七种日常口服剂量的维生素D或安慰剂。研究的主要夹杂物标准是基线血清250I-ID <20ng / ml(50nmol / L)。在基线收集秋季的历史,并每3个月收集秋季活动。结果表明,无论是用剂量还是25Ohd水平分析,维生素D对跌落的影响遵循U形曲线。低维生素D剂量400,800 IU的下降没有减少,培养基剂量的显着降低1600,2400,3200 IU(P = 0.020),与安慰剂相比,高剂量4000,4800 IU的降低(P = 0.55 )。与12个月的血清25Ohd Quintiles相比,最低荧光率<25ng / ml(<50 nmol / l)中的较低速率为60%,低中间荧光素32-38 ng / ml(80-95) NMO / L),高中荧光素38-46ng / ml(95-115 NMO / L)中的72%,最高含量46-66ng / ml(115-165米醇/ L)。在秋季历史的亚组中,低剂量下降率为68%,培养基剂量为27%,较高剂量100%。与中剂量相比,高剂量的降低率增加(差距5.6.95%CI; 2.1-14.8)。总之,下降的最大降低对应于32-38ng / ml(80-95nmol / L)的12个月血清25Ohd(80-95 nmol / L),并且随着血清25Ohd超过40-45ng / ml(100-112.5 nmol / l)。可容忍的上限(TUL)最近在2010年增加到2010年的2000年至4000 IU /日可能需要在老年妇女中减少,特别是在秋季历史的人中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号